DiscoverDiabetech - Diabetes Tech, Research, News
Diabetech - Diabetes Tech, Research, News
Claim Ownership

Diabetech - Diabetes Tech, Research, News

Author: Justin Eastzer

Subscribed: 57Played: 1,744
Share

Description

A diabetes technology podcast covering the latest diabetes news, research, treatments, and management tips. Through interviews with industry leaders, healthcare professionals, researchers, and people living with diabetes, we explore insulin pumps, continuous glucose monitors (CGMs), automated insulin delivery (AID) systems, clinical trials, emerging therapies, and advances in diabetes care. From product reviews to scientific breakthroughs and industry insights, Diabetech keeps you informed about the technology and research shaping the future of diabetes management.

181 Episodes
Reverse
Joanne Milo and Maddy Arnstein have both lived with type 1 diabetes for more than 60 years, despite being told decades ago that they might not live past 40. From urine testing and reusable injections to continuous glucose monitors and automated insulin delivery, they've experienced an incredible transformation in diabetes care. But living longer with T1D brings its own challenges, from managing complications to navigating healthcare systems that aren't always prepared to support older adults with diabetes. Their stories offer a powerful perspective on how far diabetes care has come, what still needs to change, and why community, self-advocacy, and support matter at every stage of life.   Learn about the Eversense 365 CGM   Learn about Omnipod 5 (today's sponsor)*   Visit T1D To 100   The Savvy Diabetic Blog   Join: Diabetech Newsletter (free) | Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.  
The GlucoSense app has a new feature that helps people with diabetes compare health insurance plans and estimate their annual healthcare costs. Jonathan Fitch, co-founder and CEO of GlucoSense, breaks down important factors to consider when choosing diabetes insurance coverage, including monthly premiums, deductibles, co-pays, prescription formularies, insulin prices, and coverage for continuous glucose monitors (CGMs) and insulin pumps. Fitch demonstrates how the app compares insurance plans based on diabetes medications, devices, and expected out-of-pocket expenses, helping users identify coverage that may save them money.   Learn about Omnipod 5 (today's sponsor)*   Learn about the Eversense 365 CGM   Visit GlucoSense   Join: Diabetech Newsletter (free) | Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.
Type 1 diabetes care continues to evolve, but significant challenges remain. Dr. Brynn Marks, Pediatric Endocrinologist and Senior Director of Medical Affairs at Breakthrough T1D, joins us to discuss the current state of diabetes care and research. The conversation explores gaps in access to diabetes technology, diabetes distress, the push toward fully closed-loop systems, and the importance of earlier T1D screening. Together, these topics highlight the progress being made and the work still needed to improve care and reduce the daily burden of living with T1D.   Learn about Omnipod 5 (today's sponsor)*   Learn about the Eversense 365 CGM   Learn more at Breakthrough T1D   Join: Diabetech Newsletter (free) | Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.
Eversense 365 is an implantable continuous glucose monitor designed to last for a year, but what is it like to use in everyday life? Certified diabetes care and education specialist Gary Scheiner joins us on the podcast to share his experience after 10 weeks with the sensor, including glucose reading accuracy, calibration requirements, transmitter charging, adhesive options, and on-body vibration alerts. The conversation explores how Eversense 365 compares with disposable CGMs, its use with automated insulin delivery systems, and the challenges of getting through the initial adjustment period. Plus, a look at planned improvements to Eversense and the future of implantable glucose monitoring, including technology designed to measure glucose directly in the bloodstream.   Learn about Omnipod 5 (today's sponsor)*   Learn about the Eversense 365 CGM   Integrated Diabetes - work with Gary's team   Join: Diabetech Newsletter (free) | Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.
Beta Bionics is bringing its AID technology to a new patch pump format with the FDA-cleared Mint, expected to launch in Q1 2027. Mike Mensinger, Chief Product Officer at Beta Bionics breaks down how Mint’s two-part design works, from its reusable controller, to a Mint site and smartphone app demo. Mensinger shares what’s changing with the iLet, including the upcoming 3D Intelligence algorithm and planned Eversense 365 integration. Lastly, we look ahead at Beta Bionics’ plans for future dual-hormone systems and how the Mint platform could help make those possibilities a reality.   Watch the Mint Post-Show episode   Learn about the Eversense 365 CGM   Learn about Omnipod 5 (sponsor)*   Beta Bionics iLet Real World Data   Watch Next: Bluetooth Underwater | Artificial Pancreas   Join: Diabetech Newsletter (free) | Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 
loading
Comments